
Regencell Bioscience
(NASDAQ) RGC
Regencell Bioscience Financials at a Glance
Market Cap
$3.71B
Revenue (TTM)
$0.00
Net Income (TTM)
-$8.90M
EPS (TTM)
-$0.01
P/E Ratio
-527.46
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.34
Volume
22,743
Open
$7.13
Price
$6.34
Volume
22,743
Open
$7.13
Previous Close
$6.34
Daily Range
$5.89 - $7.13
52-Week Range
$5.89 - $69.00
Estimated Earnings Date
Jun 15, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.34
Volume
22,743
Open
$7.13
Previous Close
$6.34
Daily Range
$5.89 - $7.13
52-Week Range
$5.89 - $69.00
Estimated Earnings Date
Jun 15, 2026
RGC News



RGC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Regencell Bioscience
Industry
Pharmaceuticals
Sector
Health CareEmployees
10
CEO
Yat-Gai Au
Website
www.regencellbioscience.comHeadquarters
Causeway Bay, KY1-1107, HK
RGC Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-231.87%
Return on Capital
-69.75%
Return on Assets
-233.91%
Earnings Yield
-0.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.71B
Shares Outstanding
495.47M
Volume
22.74K
Avg. Volume
151.87K
Financials (TTM)
Gross Profit
-$40.84K
Operating Income
-$9.11M
EBITDA
-$8.81M
Operating Cash Flow
-$4.00M
Capital Expenditure
-$5.38K
Free Cash Flow
-$4.01M
Cash & ST Invst.
$2.36M
Total Debt
$386.30K
Regencell Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$40.84K
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.71B
N/A
Market Cap/Employee
$309.26M
N/A
Employees
12
N/A
Net Income
-$5.32M
-514555.0%
EBITDA
-$5.30M
-358.5%
Quarterly Fundamentals
Total Cash
$2.36M
-50.9%
Total Debt
$386.30K
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$128.18K
N/A
Short Term Debt
$258.12K
N/A
Return on Assets
-2.34%
N/A
Return on Invested Capital
-5.29%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%
